Introduction: Cities located in lower income countries are global flood risk hotspots. Assessment and management of these risks forms a key part of global climate adaptation efforts. City scale flood ...

RAS is mutated in nearly 20% of human cancers and has few direct, efficacious inhibitors. Here, we developed a synthetic protein, JAM20, to discover potential regions on RAS that may be used for ...

Objectives Cetuximab plus leucovorin, fluorouracil and oxaliplatin (FOLFOX-4) is superior to FOLFOX-4 alone as a first-line treatment for patients with metastatic colorectal cancer with RAS wild-type ...

1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, KU Leuven (University of Leuven), University Hospitals Leuven, Leuven, Belgium. 2Department of Human Genetics, KU Leuven, ...